Status:
COMPLETED
Effect of Extra Virgin Olive Oil on Atherosclerosis Biomarkers in HIV-infected Patients
Lead Sponsor:
University Hospital for Infectious Diseases, Croatia
Conditions:
HIV
Atherosclerosis
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
HIV infection is associated with systemic inflammation that is involved in pathogenesis of atherosclerosis. Treatment of HIV infection may cause lipid profile disturbance and consequently, atheroscler...
Detailed Description
There are many studies about beneficial effect of extra virgin olive oil on atherosclerosis biomarkers. Our study investigates the same, but in population of HIV-infected patients receiving antiretrov...
Eligibility Criteria
Inclusion
- HIV-positive patients receiving antiretroviral drugs
- undetectable HIV viral load in plasma for at least 6 months (by high sensitive Amplicor HIV-1 Monitor, version 1.5)
- glucose level within reference range
Exclusion
- pregnant HIV-positive women
- HIV-patients with underlying acute/chronic diseases (except cardiovascular)
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT00925795
Start Date
September 1 2009
End Date
October 1 2010
Last Update
November 23 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital for Infectious Diseases "Dr Fran Mihaljevic"
Zagreb, Croatia, 10 000